209 related articles for article (PubMed ID: 32238435)
21. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
White PL; Price JS; Posso RB; Barnes RA
Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Risk Score for Predicting Invasive Candidiasis in Intensive Care Unit Patients by Incorporating Clinical Risk Factors and Lymphocyte Subtyping.
Zhang J; Cheng W; Li D; Chen J; Zhao G; Wang H; Cui N
Front Cell Infect Microbiol; 2022; 12():829066. PubMed ID: 35573797
[TBL] [Abstract][Full Text] [Related]
23. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
Nguyen MH; Wissel MC; Shields RK; Salomoni MA; Hao B; Press EG; Shields RM; Cheng S; Mitsani D; Vadnerkar A; Silveira FP; Kleiboeker SB; Clancy CJ
Clin Infect Dis; 2012 May; 54(9):1240-8. PubMed ID: 22431804
[TBL] [Abstract][Full Text] [Related]
24. Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
Liew YX; Teo J; Too IA; Ngan CC; Tan AL; Chlebicki MP; Kwa AL; Lee W
BMC Infect Dis; 2015 Jul; 15():256. PubMed ID: 26137997
[TBL] [Abstract][Full Text] [Related]
25. [The 1,3-β-d-glucan in critical adult patients as diagnostic tool for invasive Candida spp. infection, performance evaluation].
Donato L; González T; Canales M; Legarraga P; García P; Rabagliati R
Rev Chilena Infectol; 2017 Aug; 34(4):340-346. PubMed ID: 29165510
[TBL] [Abstract][Full Text] [Related]
26. Clinical value of (1,3)-β-D-glucan, mannan, antimannan IgG and IgM antibodies in diagnosis of invasive candidiasis.
Li F; Yu X; Ye L; Zhou G; Wang L; Luo Y
Med Mycol; 2019 Nov; 57(8):976-986. PubMed ID: 30820536
[TBL] [Abstract][Full Text] [Related]
27. Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.
Playford EG; Lipman J; Jones M; Lau AF; Kabir M; Chen SC; Marriott DJ; Seppelt I; Gottlieb T; Cheung W; Iredell JR; McBryde ES; Sorrell TC
Clin Infect Dis; 2016 Dec; 63(11):1463-1469. PubMed ID: 27601224
[TBL] [Abstract][Full Text] [Related]
28. Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.
Giacobbe DR; Mikulska M; Tumbarello M; Furfaro E; Spadaro M; Losito AR; Mesini A; De Pascale G; Marchese A; Bruzzone M; Pelosi P; Mussap M; Molin A; Antonelli M; Posteraro B; Sanguinetti M; Viscoli C; Del Bono V;
Crit Care; 2017 Jul; 21(1):176. PubMed ID: 28693606
[TBL] [Abstract][Full Text] [Related]
29. Clinical Sensitivity of the (1-3)-β-D-glucan Test for Predicting Candidemia.
Lee YW; Lim SY; Jin S; Park HJ; Sung H; Kim MN; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Chong YP
Ann Lab Med; 2023 Jul; 43(4):381-385. PubMed ID: 36843407
[TBL] [Abstract][Full Text] [Related]
30. Serial (1-3)-beta-D-Glucan (BDG) monitoring shows high variability among premature neonates.
Ferreras-Antolin L; Aziz N; Warris A
Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35561703
[TBL] [Abstract][Full Text] [Related]
31. A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.
Knitsch W; Vincent JL; Utzolino S; François B; Dinya T; Dimopoulos G; Özgüneş İ; Valía JC; Eggimann P; León C; Montravers P; Phillips S; Tweddle L; Karas A; Brown M; Cornely OA
Clin Infect Dis; 2015 Dec; 61(11):1671-8. PubMed ID: 26270686
[TBL] [Abstract][Full Text] [Related]
32. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
33. T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit.
Gill CM; Kenney RM; Hencken L; Mlynarek ME; Alangaden GJ; Samuel LP; Davis SL
Diagn Microbiol Infect Dis; 2019 Oct; 95(2):162-165. PubMed ID: 31248660
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults.
Lamoth F; Akan H; Andes D; Cruciani M; Marchetti O; Ostrosky-Zeichner L; Racil Z; Clancy CJ
Clin Infect Dis; 2021 Mar; 72(Suppl 2):S102-S108. PubMed ID: 33709130
[TBL] [Abstract][Full Text] [Related]
35. The influence of continuous renal replacement therapy on 1,3-β-d-glucan levels in critically ill patients: a single-center retrospective propensity score study.
Cabanilla MG; Briski MJ; Bruss Z; Saa L; Vasquez PC; Rodriguez CN; Mitchell JA; Bernauer ML; Argyropoulos CP; Crandall CS; Teixeira JP
Ren Fail; 2023; 45(2):2255680. PubMed ID: 37781748
[TBL] [Abstract][Full Text] [Related]
36. Rapid diagnosis of invasive candidiasis: ready for prime-time?
Clancy CJ; Nguyen MH
Curr Opin Infect Dis; 2019 Dec; 32(6):546-552. PubMed ID: 31567567
[TBL] [Abstract][Full Text] [Related]
37. (1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial.
De Pascale G; Posteraro B; D'Arrigo S; Spinazzola G; Gaspari R; Bello G; Montini LM; Cutuli SL; Grieco DL; Di Gravio V; De Angelis G; Torelli R; De Carolis E; Tumbarello M; Sanguinetti M; Antonelli M
Crit Care; 2020 Sep; 24(1):550. PubMed ID: 32891170
[TBL] [Abstract][Full Text] [Related]
38. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation.
Poissy J; Sendid B; Damiens S; Ichi Ishibashi K; François N; Kauv M; Favory R; Mathieu D; Poulain D
Crit Care; 2014 Jun; 18(3):R135. PubMed ID: 24975380
[TBL] [Abstract][Full Text] [Related]
39. Risk factors of invasive candidiasis in critical cancer patients after various gastrointestinal surgeries: A 4-year retrospective study.
Xia R; Wang D
Medicine (Baltimore); 2019 Nov; 98(44):e17704. PubMed ID: 31689800
[TBL] [Abstract][Full Text] [Related]
40. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients.
Fortún J; Meije Y; Buitrago MJ; Gago S; Bernal-Martinez L; Pemán J; Pérez M; Gómez-G Pedrosa E; Madrid N; Pintado V; Martín-Dávila P; Cobo J; Fresco G; Moreno S; Cuenca-Estrella M
J Antimicrob Chemother; 2014 Nov; 69(11):3134-41. PubMed ID: 24970743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
